Does shared decision making exist in oncologic practice?

References

• Stiggelbout AM, Van der Weijden T, De Wit MP, Frosch D, Legare F, Montori VM, et al. Shared decision making: Really putting patients at the centre of healthcare. Br Med J 2012;344:e256.
   PubMed Web of Science ®Google Scholar
• Shay LA, Lafata JE. Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Making 2015;35:114–31.
   PubMed Web of Science ®Google Scholar
• Kunneman M et al. Deciding about (neo-)adjuvant rectal and breast cancer treatment: Missed opportunities for shared decision making. Acta Oncol Epub 2015 Aug 3.
   Web of Science ®Google Scholar
• Glimelius B. Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future. Ups J Med Sci 2012;117:225–36.
   PubMed Web of Science ®Google Scholar
• Birgisson H, Påhlman L, Gunnarsson U, Glimelius B. Late adverse effects of radiation therapy for rectal cancer – a systematic overview. Acta Oncol 2007;46:504–16.
   PubMed Web of Science ®Google Scholar
• Grau C, Overgaard J, Hoyer M, Tanderup K, Lindegaard JC, Muren LP. Biology-guided adaptive radiotherapy (BiGART) is progressing towards clinical reality. Acta Oncol 2015;54:1–6.
   PubMed Web of Science ®Google Scholar
• Valentini V, Aristei C, Glimelius B, Minsky BD, Beets-Tan R, Borras JM, et al. Multidisciplinary rectal cancer management. Radiother Oncol 2009;92:148–63.
   PubMed Web of Science ®Google Scholar
• Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol 2012;23:2479–516.
   PubMed Web of Science ®Google Scholar
• Glimelius B, Tiret E, Cervantes A, Arnold D, Group EGW. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(Suppl 6):vi81–8.
   PubMed Web of Science ®Google Scholar
• Dutch Cancer Society and Comprehensive Cancer Centers. The Netherlands. Cijfers over borstkanker. Available from: http://www.oncoline.nl/mammacarcinoom. 2013. Accessed August 24 2015.
   Google Scholar
• National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines). Breast cancer version. Available from: http://www.nccn.org/professionals/physician.gls/pdf/breast.pdf. 2014. Accessed August 24 2015.
   Google Scholar
• Engelhardt EG, de Haes HC, van de Velde CJ, Smets EM, Pieterse AH, Stiggelbout AM. Oncologists’ weighing of the benefits and side effects of adjuvant systemic therapy: Has it changed over time? Acta Oncol 2015;54:956–9.
   PubMed Web of Science ®Google Scholar
• Stiggelbout AM, de Haes JC, van de Velde CJ. Adjuvant chemotherapy in node negative breast cancer: Patterns of use and oncologists’ preferences. Ann Oncol 2000;11:631–3.
   PubMed Web of Science ®Google Scholar
• Breugom AJ, Swets M, Bosset JF, Collette L, Sainato A, Cionini L, et al. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: A systematic review and meta-analysis of individual patient data. Lancet Oncol 2015;16:200–7.
   PubMed Web of Science ®Google Scholar
• Bujko K, Glimelius B, Valentini V, Michalski W, Spalek M. Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery +/- a fluoropyrimidine and surgery + a fluoropyrimidine +/- oxaliplatin. Eur J Surg Oncol 2015;41:713–23.
   PubMed Web of Science ®Google Scholar
• Poulsen LO, Qvortrup C, Pfeiffer P, Yilmaz M, Falkmer U, Sorbye H. Review on adjuvant chemotherapy for rectal cancer – why do treatment guidelines differ so much? Acta Oncol 2015:54:437–46.
   PubMed Web of Science ®Google Scholar
• Glimelius B. Adjuvant chemotherapy for patients with rectal cancer – will the controversy be resolved? Acta Oncol 2015;54:433–6.
   PubMed Web of Science ®Google Scholar
• Bockelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B. Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature. Acta Oncol 2015;54:5–16.
   PubMed Web of Science ®Google Scholar
• Nielsen MH, Berg M, Pedersen AN, Andersen K, Glavicic V, Jakobsen EH, et al. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: National guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol 2013;52:703–10.
   PubMed Web of Science ®Google Scholar
• Varga Z, Cserhati A, Rarosi F, Boda K, Gulyas G, Egyud Z, et al. Individualized positioning for maximum heart protection during breast irradiation. Acta Oncol 2014;53:58–64.
   PubMed Web of Science ®Google Scholar
• Lorenzen EL, Ewertz M, Brink C. Automatic segmentation of the heart in radiotherapy for breast cancer. Acta Oncol 2014;53:1366–72.
   PubMed Web of Science ®Google Scholar
• Swedish National Colorectal Cancer Quality Register. Available from: https://www.cancercentrum.se/globalassets/cancerdiagnoser/tjock-och-andtarm/kvalitetsregister/onkolograpport-2013_20150129.pdf. 2013. Accessed August 24 2015.
   Google Scholar
• Breugom AJ, van Gijn W, Muller EW, Berglund A, van den Broek CB, Fokstuen T, et al. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: A Dutch Colorectal Cancer Group (DCCG) randomized phase III trial. Ann Oncol 2015;26:696–701.
   PubMed Web of Science ®Google Scholar
• Brannstrom F, Bjerregaard JK, Winbladh A, Nilbert M, Revhaug A, Wagenius G, et al. Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer. Acta Oncol 2015;54:447–53.
   PubMed Web of Science ®Google Scholar
• Timmermans LM, van Zuuren FJ, van der Maazen RW, Leer JW, Kraaimaat FW. Monitoring and blunting in palliative and curative radiotherapy consultations. Psychooncology 2007;16:1111–20.
   PubMed Web of Science ®Google Scholar